OpenLegislation

Chapter 6 INCENTIVESF1

United Kingdom Repealed

Original text. Later amendments are not shown.

  1. 16Scientific advice
  2. 17Scientific recommendation on advanced therapy classification
  3. 18Certification of quality and non-clinical data
  4. 19Reduction of the fee for marketing authorisation

Annotations

Textual amendments

F1

Regulation revoked (in so far as it applies to medicinal products for human use) (31.12.2020) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), reg. 1, Sch. 9 para. 1(o) (subject to transitional provisions in S.I. 2012/1916, Sch. 33A); 2020 c. 1, Sch. 5 para. 1(1)